Real-world study tracks prostate cancer treatment duration
NCT ID NCT07086651
First seen Dec 08, 2025 · Last updated May 15, 2026 · Updated 19 times
Summary
This study reviewed medical records from over 1,300 men with metastatic castration-sensitive prostate cancer to see how long they actually take the drugs apalutamide or enzalutamide. It is not a clinical trial but an observation of real-world treatment patterns. The goal is to understand treatment duration outside of controlled research settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer, Inc
New York, New York, 10001, United States
Conditions
Explore the condition pages connected to this study.